5 insiders reported 99 Form 4 transactions for BELITE BIO, INC (BLTE) over the past 18 months (most recent 2026-06-22). Recent activity: Scholl Hendrik Peter (Chief Medical Officer) Sell 96 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 3,748 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 4,861 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 1,199 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 96 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 96 | $13,814 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 3,748 | $542,192 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 4,861 | $706,959 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 1,199 | $175,348 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 96 | $14,123 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 1,035 | $150,097 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 784 | $108,331 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 3,140 | $438,260 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 540 | $75,915 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 100 | $14,183 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 450 | $63,988 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 1,897 | $272,314 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 2,054 | $282,641 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 226 | $34,453 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 428 | $65,725 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 3 | $464 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 9 | $1,397 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 8 | $1,213 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 424 | $64,733 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 128 | $19,638 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 240 | $37,059 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 100 | $15,597 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 100 | $15,600 |
| 2026-05-01 | MATA NATHAN L. | Chief Scientific Officer | Sell | 42 | $6,538 |
| 2026-05-01 | MATA NATHAN L. | Chief Scientific Officer | Sell | 517 | $80,955 |
Source: SEC Form 4 filings · as of 2026-06-22